BioSpace News Archive

Business

Viridian Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Updates

Viridian Therapeutics, Inc. today announced financial results for the second quarter ended June 30, 2021, and provided corporate updates.

August 11, 2021
·
12 min read
BioMidwest

Stryker Launches SurgiCount+ Safety-Sponge System

Stryker, one of the world’s leading medical technology companies, announced the launch of SurgiCount™+ Safety-Sponge System, its next generation surgical sponge counting technology.

August 11, 2021
·
2 min read
Biotech Beach

PYC Therapeutics to Host Quarterly Investor Call on August 17 at 9 a.m. AWST | 11 a.m. AEST

PYC Therapeutics today announced it will host an investor call on August 17, 2021 at 9 a.m. AWST/11 a.m.

August 11, 2021
·
2 min read
BioCapital

As Delta Variant and Respiratory Viruses Surge in the U.S., Many Turn to Single Test for COVID/Influenza/RSV and Faster COVID-19 PCR Variant Test by GENETWORx

Since many of these viruses share a multitude of strikingly similar symptoms, a single PCR test that differentiates between three primary pathogens, influenza A and B, RSV, and COVID-19, is becoming increasingly popular with physicians and patients, according to leading national laboratory GENETWORx.

August 11, 2021
·
4 min read
Business

Optinose Reports Second Quarter 2021 Financial Results and Recent Operational Highlights

Optinose, a pharmaceutical company focused on patients treated by ear, nose and throat and allergy specialists, reported financial results for the quarter ended June 30, 2021, and provided operational updates.

August 11, 2021
·
11 min read
Business

C4 Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results

C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering a new class of small-molecule medicines that selectively destroy disease-causing proteins through degradation, reported business highlights and financial results for the second quarter of 2021.

August 11, 2021
·
10 min read
Business

Entasis Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update

Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, announced today financial results for the second quarter 2021 and issued a business update for the quarter and recent weeks.

August 11, 2021
·
9 min read
Business

MannKind Corporation Reports 2021 Second Quarter Financial Results

MannKind Corporation reported financial results for the quarter and six months ended June 30, 2021.

August 11, 2021
·
18 min read
Business

Biomea Fusion Reports Second Quarter 2021 Financial Results and Business Highlights

Biomea Fusion, Inc., a preclinical-stage biopharmaceutical company focused on the discovery and development of irreversible small molecules to treat patients with genetically defined cancers, reported financial results for the second quarter of 2021.

August 11, 2021
·
10 min read
Business

Femasys Inc. Announces Financial Results for the Second Quarter of 2021

Femasys Inc. (NASDAQ: FEMY), a biomedical company developing a suite of product candidates to transform women’s healthcare with minimally invasive, non-surgical, in-office technologies, today announced financial results for the second quarter and six months ended June 30, 2021.

August 11, 2021
·
11 min read